SHARON TETLOW
CIK 1328565 · Acting CFO & Treasurer · last filed 2026-06-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.3K
Companies
4
Total Filings
17
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GPCR | Director | — | $47.13 | — | $0 | 3 | 2026-06-18 |
| DICE Therapeutics, Inc. (DICE) Delisted | Director | 0 | $47.55 | $0 | $0 | 3 | 2023-08-09 |
| CBIO | Director | 242 | $17.93 | $4.3K | $0 | 5 | 2021-07-02 |
| CELL GENESYS INC (CEGE) Delisted | SVP & CFO | 0 | — | — | $0 | 5 | 2009-10-15 |
Recent Filings · Page 2 of 2
17 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-01-17 | CBIO | Grant (A) | — | $0 | EDGAR |
| 2014-07-15 | — | Buy (P) | +3,000 | $17.5K | |
| 2009-10-15 | CELL GENESYS INC (CEGE) Delisted | Disp (D) | −18,449 | $0 | EDGAR |
| 2008-08-01 | CELL GENESYS INC (CEGE) Delisted | Tax (F) | −9,051 | -$28.1K | EDGAR |
| 2008-02-08 | CELL GENESYS INC (CEGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-08-01 | CELL GENESYS INC (CEGE) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
| 2007-02-09 | CELL GENESYS INC (CEGE) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–17 of 17
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.